Skip to main content
. 2021 Jan 19;35(4):634–644. doi: 10.1111/fcp.12635

Figure 2.

Figure 2

Analyses of ICAM‐1 revealing no significant differences among the control, simvastatin, and combination therapy groups (a). The simvastatin group exhibited significantly elevated BDNF levels at all time points, while the combination therapy group exhibited significantly elevated BDNF levels at the 24‐h and 72‐h time points (b). *P < 0.05 for Bonferroni post hoc comparison vs. the simvastatin group; P < 0.05 for Bonferroni post hoc comparison vs. the combination group. Data are presented as means ± standard errors. ICAM‐1, intercellular adhesion molecule‐1; BDNF, brain‐derived neurotrophic factor.